Methylphenidate enhances neural stem cell differentiation

BACKGROUND: The psychostimulant methylphenidate (MPH) is the first choice of drug treatment in Attention-Deficit/Hyperactivity Disorder (ADHD). Since therapy often begins at a time when the brain is still developing and the long-term consequences of MPH are still not fully clarified, we examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartl, Jasmin, Mori, Takatoshi, Riederer, Peter, Ozawa, Hiroki, Grünblatt, Edna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224010/
https://www.ncbi.nlm.nih.gov/pubmed/25408898
http://dx.doi.org/10.1186/2049-9256-1-5
Descripción
Sumario:BACKGROUND: The psychostimulant methylphenidate (MPH) is the first choice of drug treatment in Attention-Deficit/Hyperactivity Disorder (ADHD). Since therapy often begins at a time when the brain is still developing and the long-term consequences of MPH are still not fully clarified, we examined the influences of an acute treatment with MPH on the differentiation and proliferation of murine neural stem cells (mNSC). FINDINGS AND CONCLUSION: We found that MPH enhanced neuronal differentiation and inhibited neural proliferation.

Ejemplares similares